Rathbones Group’s DexCom DXCM Stock Holding History

Rathbones Group’s Portfolio DXCM Stock Details DXCM Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3.8M	Sell	56,360 -7,634	-12%	-$509K	0.01%	244
2026 Q1	$4.02M	Sell	63,994 -55,897	-47%	-$3.89M	0.02%	232
2025 Q4	$7.96M	Sell	119,891 -18,632	-13%	-$1.2M	0.03%	174
2025 Q3	$9.32M	Sell	138,523 -551,828	-80%	-$43.7M	0.04%	166
2025 Q2	$60.3M	Sell	690,351 -396,518	-36%	-$31.1M	0.26%	90
2025 Q1	$74.2M	Sell	1,086,869 -72,144	-6%	-$5.89M	0.36%	74
2024 Q4	$90.1M	Buy	1,159,013 +24,314	+2%	+$1.8M	0.44%	61
2024 Q3	$76.1M	Sell	1,134,699 -267,103	-19%	-$21.9M	0.38%	74
2024 Q2	$159M	Buy	1,401,802 +76,727	+6%	+$9.7M	0.87%	29
2024 Q1	$184M	Sell	1,325,075 -19,259	-1%	-$2.42M	1.06%	25
2023 Q4	$167M	Buy	1,344,334 +82,120	+7%	+$8.39M	1.08%	23
2023 Q3	$118M	Buy	1,262,214 +120,870	+11%	+$13.6M	0.85%	32
2023 Q2	$147M	Sell	1,141,344 -22,657	-2%	-$2.74M	1.37%	17
2023 Q1	$135M	Sell	1,164,001 -31,552	-3%	-$3.53M	1.38%	20
2022 Q4	$135M	Sell	1,195,553 -66,694	-5%	-$7.32M	1.52%	17
2022 Q3	$102M	Sell	1,262,247 -4,300	-0.3%	-$364K	1.25%	23
2022 Q2	$94.4M	Buy	1,266,547 +76,723	+6%	+$7M	1.08%	26
2022 Q1	$152M	Buy	1,189,824 +129,900	+12%	+$14.2M	1.55%	16
2021 Q4	$142M	Sell	1,059,924 -3,432	-0.3%	-$493K	1.38%	18
2021 Q3	$145M	Sell	1,063,356 -43,648	-4%	-$5.5M	1.56%	13
2021 Q2	$118M	Buy	1,107,004 +791,928	+251%	+$76.1M	1.31%	18
2021 Q1	$28.3M	Buy	315,076 +117,456	+59%	+$11M	0.36%	72
2020 Q4	$18.3M	Buy	197,620 +168,836	+587%	+$15.1M	0.26%	84
2020 Q3	$2.97M	Buy	28,784 +2,696	+10%	+$282K	0.05%	156
2020 Q2	$2.64M	Buy	26,088 +10,000	+62%	+$895K	0.05%	149
2020 Q1	$1.08M	Buy	16,088 +88	+0.6%	+$5.48K	0.03%	168
2019 Q4	$875K	Hold	16,000	–	–	0.02%	197
2019 Q3	$597K	Hold	16,000	–	–	0.02%	221
2019 Q2	$599K	Hold	16,000	–	–	0.02%	212
2019 Q1	$476K	Hold	16,000	–	–	0.02%	223
2018 Q4	$479K	Hold	16,000	–	–	0.02%	224
2018 Q3	$572K	Hold	16,000	–	–	0.02%	212
2018 Q2	$380K	Hold	16,000	–	–	0.01%	232
2018 Q1	$297K	Hold	16,000	–	–	0.01%	251
2017 Q4	$230K	Buy	+16,000	New	+$208K	0.01%	279
2017 Q3	–	Sell	-16,000	Closed	-$293K	–	319
2017 Q2	$293K	Buy	16,000 +800	+5%	+$14.8K	0.01%	249
2017 Q1	$322K	Hold	15,200	–	–	0.01%	243
2016 Q4	$227K	Hold	15,200	–	–	0.01%	271
2016 Q3	$333K	Hold	15,200	–	–	0.02%	234
2016 Q2	$301K	Hold	15,200	–	–	0.02%	235
2016 Q1	$258K	Hold	15,200	–	–	0.02%	236
2015 Q4	$275K	Hold	15,200	–	–	0.02%	236
2015 Q3	$326K	Hold	15,200	–	–	0.02%	227
2015 Q2	$304K	Hold	15,200	–	–	0.02%	248
2015 Q1	$237K	Hold	15,200	–	–	0.02%	277
2014 Q4	$209K	Buy	+15,200	New	+$186K	0.01%	293

Other funds holding DXCM

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return

Rathbones Group's DXCM Position: Q2 2026 in Review

Rathbones Group reduced its DexCom (DXCM) stake by 12% in Q2 2026, selling an estimated $509K and leaving 56,360 shares worth $3.8M. The position accounts for 0.01% of the portfolio, ranked #244.

Rathbones Group first reported a position in DXCM in Q4 2014 and has held it in 46 quarters since. The position peaked at $184M in Q1 2024. 968 funds tracked by Wall St. Rank hold DXCM as of Q2 2026.

Rathbones Group held 56,360 shares of DexCom worth $3.8M as of Q2 2026.
Rathbones Group sold 7,634 DexCom shares in Q2 2026, an estimated $509K.
DexCom made up 0.01% of Rathbones Group's portfolio in Q2 2026, its #244 holding.
Rathbones Group first reported a position in DexCom in Q4 2014 and has held it in 46 quarters since.
Rathbones Group's DexCom position peaked at $184M in Q1 2024.
968 funds tracked by Wall St. Rank held DexCom as of Q2 2026.

Based on Rathbones Group's 13F filing for Q2 2026, filed 23 Jul 2026.